Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2003
09/18/2003WO2003075930A1 Synergistic enhancement of cognitive ability
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075923A1 Vdac regulator
09/18/2003WO2003075922A1 Nitrogen monoxide synthase inhibitors
09/18/2003WO2003075921A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
09/18/2003WO2003075909A1 Ibuprofen solution for hard shell capsules
09/18/2003WO2003075906A1 Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
09/18/2003WO2003075895A1 Tasted masked veterinary solid compositions
09/18/2003WO2003075893A1 Controlled release dosage forms
09/18/2003WO2003075887A1 Sustained release drug formulations containing a carrier peptide
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075850A2 Methods for alzheimer's disease treatment and cognitive enhancement
09/18/2003WO2003075670A1 Treatment and prevention of inflammatory disorders
09/18/2003WO2003059252A3 Use of a novel cell surface protease from group b streptococcus
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003051893A3 Improvements in pharmaceutical compositions
09/18/2003WO2003051807A3 Improvements in pharmaceutical compositions
09/18/2003WO2003048122A3 Inhibitors of cytosolic phospholipase a2
09/18/2003WO2003046135A3 Osteopontin-related compositions and methods
09/18/2003WO2003045392A3 Use of n-(indolcarbonyl-)piperazine derivatives
09/18/2003WO2003039454A8 Beta-secretase inhibitors and methods of use
09/18/2003WO2003037308A3 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
09/18/2003WO2003031584A3 Axon repair
09/18/2003WO2003024472A3 Prolactin induced increase in neutral stem cell numbers and therapeutical use thereof
09/18/2003WO2003024419A3 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
09/18/2003WO2003018782A3 Differentiation of neural stem cells and therapeutic use theeof
09/18/2003WO2003007926A3 Pharmaceutical composition comprising deramciclane for the treatment of the decline and/or damage of cognitive functions
09/18/2003WO2002102388A3 Active ingredient combination of e.g. galanthamine or deoxypeganine and e.g. acamprosate or memantine for treating an addiction such as alcoholism
09/18/2003WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
09/18/2003WO2002076925A3 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003WO2002053177A3 Agents and methods for treating pain
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176699 Purine inhibitors of protein kinases, G proteins and polymerases
09/18/2003US20030176695 Such as N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-2-methyl-isonicotinamide for treatment of disorders of the central nervous system; neuroprotectants
09/18/2003US20030176694 Fused heterocyclic compounds
09/18/2003US20030176693 Diphenylalkylamine derivatives useful as opioid receptor agonists
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176651 Multiprotein-complex comprising a nmda receptor and uses thereof
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176642 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176496 Administering an antiproliferative agent in combination with a potentiating effective amount of a N- substituted dithiocarbamate ester or a pharmaceutically acceptable salt thereof
09/18/2003US20030176491 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer
09/18/2003US20030176489 Glyt-1 inhibitors
09/18/2003US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders
09/18/2003US20030176481 Novel imidazole derivatives with anti-inflammatory activity
09/18/2003US20030176478 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease
09/18/2003US20030176476 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/18/2003US20030176475 For therapy of disorders of the gastrointestinal system, and of the central nervous system
09/18/2003US20030176465 Cyclic amino acid derivatives
09/18/2003US20030176462 Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders
09/18/2003US20030176455 Inhibiting cell death following cellular regeneration in a mammal in need thereof, which comprises providing with an effective amount of a rapamycin
09/18/2003US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/18/2003US20030176450 Pyrazolopyrimidines
09/18/2003US20030176449 For therapy and prophylaxis of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders
09/18/2003US20030176448 Mitochondria protecting agents for treating mitochondria associated diseases
09/18/2003US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
09/18/2003US20030176434 Compounds and methods for promoting smoking cessation
09/18/2003US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases
09/18/2003US20030176425 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
09/18/2003US20030176418 For therapy of Alzheimer's disease, Parkinson's disease, schizophrenia, Huntington's chorea, Friederich's ataxia, Gilles de la Tourette's Syndrome, Down Syndrome, Pick disease, dementia, clinical depression, age- related cognitive decline
09/18/2003US20030176416 For therapy of disease, disorder or condition is responsive to modulation of cholinergic receptors and/or monoamine receptors
09/18/2003US20030176415 1,2,3,4-tetrahydroisoquinoline derivatives
09/18/2003US20030176405 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
09/18/2003US20030176365 To improve cerebral function
09/18/2003US20030176363 For therapy of T lymphocyte mediated inflammatory diseases in animals and man
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176339 For therapy and prophylaxis of diabetes, obesity, arteriosclerosis, hyperlipemia, hypertriglyceridemia, hypo-high density lipoproteinemia, hypoapolipoproteinemia A-I or nervous disorders
09/18/2003US20030176336 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
09/18/2003US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer
09/18/2003US20030176324 Derivatives of water insoluble drugs which exhibit good activity and water solubility
09/18/2003US20030176318 Administering a therapeutically effective amount of a temporary p53 inhibitor to an individual suffering from the disease or condition
09/18/2003US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
09/18/2003US20030175901 Genetic engineering; polyketides
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175876 a neurotrophin with biological activity on the central/peripheral nervous system cells; used for treating GDNF-responsive conditions such as alzhiemer's, parkinsons; device for nerve damage treatment
09/18/2003US20030175857 Of given sequence termed Con-218; constructs and recombinant host cells incorporating the genes; antibodies ; used as therapeutic target and to purify G-proteins
09/18/2003US20030175832 Diagnosing nervous system disorder via presence of aberrant macrophages in blood
09/18/2003US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering
09/18/2003US20030175775 Ligand for G-protein coupled receptor GPR43 and uses thereof
09/18/2003US20030175741 PCP-administered (phencyclidine/angel dust) chronic animal models; drug screening
09/18/2003US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays
09/18/2003US20030175679 Detecting modulators of ubiquitin conjugating enzyme complex formation; drug screening
09/18/2003US20030175374 Oxidation resistance; anticancer agents, antiinflammatory agents; sunscreen agents
09/18/2003US20030175361 Using selenium in combination with drugs used conventionally to treat psychiatric or neurological disorders
09/18/2003US20030175350 Containing thyrotropin-releasing hormone or derivatives thereof as medicinally active ingredient; excellent in absorbability
09/18/2003US20030175343 Controlled release pharmaceutical composition containing tramadol hydrochloride
09/18/2003US20030175334 Phospholipid bodies and use thereof in medical treatment
09/18/2003US20030175290 Molecular antigen array
09/18/2003US20030175280 Antagonists to chaperonin 10
09/18/2003US20030175209 Image diagnosis of a brain tumor, renal carcinoma; tumor treatment therapies, immunotherapy
09/18/2003CA2482191A1 Spiro compounds with npy antagonistic activity
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2479036A1 Aryl substituted pyrimidines and the use thereof
09/18/2003CA2478945A1 Cyclic amides
1 ... 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 ... 1833